Vivigen cellular bone matrix    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
70広範脊柱管狭窄症1

70. 広範脊柱管狭窄症 [臨床試験数:91,薬物数:195(DrugBank:54),標的遺伝子数:60,標的パスウェイ数:85
Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 91 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04007094
(ClinicalTrials.gov)
February 12, 201924/4/2019Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar SurgeryA Prospective, Single Arm Study of Patients Undergoing Posterolateral Lumbar Fusion (Without Interbody) Supplemented With ViviGen Cellular Bone MatrixDegenerative Disc Disease;Spinal Stenosis;Spondylosis;SpondylolisthesisDrug: ViviGen Cellular Bone MatrixOhio State UniversityDePuy SynthesRecruiting18 YearsN/AAll50Phase 4United States